MedPath

Surgical Treatment for Morbid Obesity by Sleeve Gastrectomy Versus Gastric Bypass

Not Applicable
Completed
Conditions
Obesity
Interventions
Procedure: Gastric Bypass
Procedure: Sleeve gastrectomy
Registration Number
NCT00722995
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of this study is to assess that the sleeve gastrectomy can improve the risk benefit than the gastric bypass

Detailed Description

In the obese patient population, the frequency of patients presenting a severe morbid obesity (40 \>= BMI \<= 50), a super obesity (BMI \>50), a super super obesity (BMI\>60), and obese patients (BMI\>35) with a failure of gastric banding is constantly increasing. In these patients, the surgery risk is proportionate to the weight and / or gastric surgery records.

This risk is high, in bariatric surgery, for gastric bypass procedure. This justifies the evaluation of new procedure to reduce the morbidity allowing the reduction of morbid /mortality associated with the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Patient aged from 18 to 60 years old

  • Patient having given his consent to the use of data from the project

  • Patient fulfilling the inclusion criteria for surgery of obesity according to the ANAES (french national health service)

  • Patient presenting one of the following criteria:

    • A morbid obesity strict with BMI> 40
    • A super obesity BMI> 50
    • A super super obesity BMI> 60
    • Obese patient in failure following the installation of a gastric banding with BMI> 35
    • obese patient 35>BMI>40 with a comorbidity
  • Preliminary agreement during the consultation of a psychiatrist / psychologist

Read More
Exclusion Criteria
  • Patient with complications or co morbidities associated involving life to less 6 months
  • Patient presenting no anaesthetic indication
  • Patient presenting no psychiatric indication for obesity surgery
  • Patient not affiliated with a social security scheme
  • Pregnant Patient likely to breastfeed in the first year
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Gastric BypassGastric Bypass
1Sleeve gastrectomySleeve gastrectomy
Primary Outcome Measures
NameTimeMethod
Composite criteria of morbid/mortalityduring 18 months and 36 months
Secondary Outcome Measures
NameTimeMethod
Frequency of morbid eventsduring the follow up
Rate serum ghrelinat inclusion visit, 6, 12, 18 and 36 months
Evaluation of quality of life and scores of precariousness, SF 36, EPWORTH Score, Lequesne' Score, Insecure' Scoreat inclusion visit, 6, 12, 18 and 36 months
Percentage of excess weight lossduring 18 and 36 months
Frequency of patients having a excess weight loss superior than 50%during 36 months
Regression of morbiditiesduring 36 months
Frequency of morbid/mortality eventsduring 36 months
Frequency of patients having excess weight loss superior than 50%during 18 month

Trial Locations

Locations (1)

Service de chirurgie digestive / Centre Hospitalier Général de Saint-Denis Delafontaine

🇫🇷

Saint-Denis, France

© Copyright 2025. All Rights Reserved by MedPath